Table 1.

Recipient and donor characteristics.

	2020 (n = 21)	2019 (n = 21)	P-value
Recipient characteristics
Male	16 (76%)	15 (71%)	.99
Age, years	56 [51–65]	58 [56–62]	.72
Etiology of cirrhosis			.15
Viral	4 (20%)	11 (52%)
Alcoholic	7 (35%)	5 (24%)
AIH and cholestatic disorders	5 (25%)	1 (5%)
NASH	2 (10%)	1 (5%)
Others	2 (10%)	3 (14%)
Etiology of ALF
Viral	1 (5%)	0
HCC in cirrhotic patients	9 (45%)	8 (38%)	.75
Blood type			.63
A	12 (57%)	11 (52%)
B	2 (10%)	5 (24%)
AB	1 (5%)	1 (5%)
0	6 (29%)	4 (19%)
Multiple organs transplant	3 (14%)	1 (5%)	.61
MELD at LT	17 [12–22]	13 [9–18]	.13
Donor characteristic
Age, years	58 [38–72]	60 [51–63]	.45
Donor after cardiac death	1 (5%)	0	.99
Suboptimal graft	10 (48%)	7 (33%)	.53
Regional donors	18 (86%)	16 (76%)	.69
Transplant operation
Ex vivo machine perfusion	4 (19%)a	6 (29%)	.72
Cold Ischemia Time, minutes	452 [346–473]	431 [393–495]	.99
Post-transplant course
EAD	5 (24%)	7 (33%)	.73
ICU-stay, days	5 [4], [5], [6], [7]	4 [3], [4], [5], [6]	.69
Hospital-stay, days	11 [10], [11], [12], [13], [14], [15], [16], [17]	13 [8–21]	.82
Discharge home	20b (95%)	21 (100%)	1

Abbreviations: AIH, autoimmune hepatitis; EAD, early graft dysfunction, according to Olthoff; HCC, hepatocellular carcinoma; ICU, intensive care unit; LT, liver transplantation; MELD, Model for the End-stage Liver Disease; NASH, non-alcoholic steato-hepatitis.

^aOne out of four with normothermic machine perfusion.

^bOne still hospitalized (combined lung-liver-pancreas transplant).